MDT vs BSX — Key Metrics

Metric MDT (MEDTRONIC PLC) BSX (BOSTON SCIENTIFIC CORP)
Price100.7243.64
Market Cap128.83 Billion63.26 Billion
P/E (TTM)24.6318.34
P/B (Quarterly)2.3712.506
P/S (TTM)3.433.0
Net Profit Margin (TTM)13.916.6
Gross Margin (TTM)65.069.1
ROE (TTM)10.613.9
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

MEDTRONIC PLC
vs
 
BOSTON SCIENTIFIC CORP
 
MEDTRONIC PLC
vs
 
BOSTON SCIENTIFIC CORP
Performance Comparison
AI Model Recommendation
MDT · MEDTRONIC PLC

Outperform

14
UnderperformOutperform
BSX · BOSTON SCIENTIFIC CORP

Greatly Outperform

84
UnderperformOutperform
Recommendation Summary

Stock MDT is projected to outperform the market, stock BSX is projected to greatly outperform the market. Upfront Recommendation: BSX.

Financial Metrics
Prices delayed ~15 min
MDT Metrics BSX
$100.72 Price $43.64
— Market Capitalization —
24.63 Price to Earnings Ratio 18.34
3.43 Price to Sales 3.0
21.01 Price to FCF Ratio 18.99
5.28 Price to Gross Profit 4.34
44.15 Price to R&D 29.3
5.28 Price to Current Assets 7.75

MDT vs BSX at a glance

Medtronic PLC (MDT) and Boston Scientific Corp (BSX) are both Medical Devices companies in the Healthcare sector. MDT is the larger, at $128.8 billion in market value against $63.3 billion for BSX, about 2.0 times the size.

On trailing-twelve-month figures, MDT trades at 24.6 times trailing earnings and BSX at 18.3; net profit margins are 13.9% and 16.6%.

The Upfront Investment model currently rates MDT Outperform and BSX Greatly Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.